1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Psychobiotics Market
4. Executive Summary
5. Voice of Customer
5.1.
Brand Awareness
5.2.
Preferred Mode of Purchase
5.3.
Major Factors Contributing to Mental Illness
5.4.
Willingness towards Psychobiotics Consumption
5.5.
Commonly Observed Psychological Effect Post Consumption
6. Global Psychobiotics
Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients,
Infant Formula)
6.2.2. By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus,
Clostridium, Others)
6.2.3. By Form (Powder, Liquid/Fluid, Tablets)
6.2.4. By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug
Store/Pharmacy, Online)
6.2.5. By Application (Gastrointestinal Function, Antidepressant, Anxiolytic,
Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder,
Schizophrenia, Others)
6.2.6. By Company (2021)
6.2.7. By Region
6.3.
Product Market Map
7. North America
Psychobiotics Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Type
7.2.2. By Psychotropic Agent
7.2.3. By Form
7.2.4. By Distribution Channel
7.2.5. By Application
7.2.6. By Country
7.3.
North America: Country Analysis
7.3.1. United States
Psychobiotics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Psychotropic Agent
7.3.1.2.3.
By Form
7.3.1.2.4.
By Distribution Channel
7.3.1.2.5.
By Application
7.3.2. Mexico Psychobiotics
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Psychotropic Agent
7.3.2.2.3.
By Form
7.3.2.2.4.
By Distribution Channel
7.3.2.2.5.
By Application
7.3.3. Canada Psychobiotics
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Psychotropic Agent
7.3.3.2.3.
By Form
7.3.3.2.4.
By Distribution Channel
7.3.3.2.5.
By Application
8. Europe Psychobiotics
Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value &
Volume
8.2.
Market Share & Forecast
8.2.1. By Type
8.2.2. By Psychotropic Agent
8.2.3. By Form
8.2.4. By Distribution Channel
8.2.5. By Application
8.2.6. By Country
8.3.
Europe: Country Analysis
8.3.1. France Psychobiotics
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Psychotropic Agent
8.3.1.2.3.
By Form
8.3.1.2.4.
By Distribution Channel
8.3.1.2.5.
By Application
8.3.2. Germany
Psychobiotics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Psychotropic Agent
8.3.2.2.3.
By Form
8.3.2.2.4.
By Distribution Channel
8.3.2.2.5.
By Application
8.3.3. United Kingdom
Psychobiotics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Psychotropic Agent
8.3.3.2.3.
By Form
8.3.3.2.4.
By Distribution Channel
8.3.3.2.5.
By Application
8.3.4. Italy Psychobiotics
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Psychotropic Agent
8.3.4.2.3.
By Form
8.3.4.2.4.
By Distribution Channel
8.3.4.2.5.
By Application
8.3.5. Spain Psychobiotics
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Psychotropic Agent
8.3.5.2.3.
By Form
8.3.5.2.4.
By Distribution Channel
8.3.5.2.5.
By Application
8.3.6. Sweden Psychobiotics
Market Outlook
8.3.6.1.
Market Size & Forecast
8.3.6.1.1.
By Value
8.3.6.2.
Market Share & Forecast
8.3.6.2.1.
By Type
8.3.6.2.2.
By Psychotropic Agent
8.3.6.2.3.
By Form
8.3.6.2.4.
By Distribution Channel
8.3.6.2.5.
By Application
8.3.7. Poland Psychobiotics
Market Outlook
8.3.7.1.
Market Size & Forecast
8.3.7.1.1.
By Value
8.3.7.2.
Market Share & Forecast
8.3.7.2.1.
By Type
8.3.7.2.2.
By Psychotropic Agent
8.3.7.2.3.
By Form
8.3.7.2.4.
By Distribution Channel
8.3.7.2.5.
By Application
8.3.8. Slovakia
Psychobiotics Market Outlook
8.3.8.1.
Market Size & Forecast
8.3.8.1.1.
By Value
8.3.8.2.
Market Share & Forecast
8.3.8.2.1.
By Type
8.3.8.2.2.
By Psychotropic Agent
8.3.8.2.3.
By Form
8.3.8.2.4.
By Distribution Channel
8.3.8.2.5.
By Application
9. Asia-Pacific
Psychobiotics Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value &
Volume
9.2.
Market Share & Forecast
9.2.1. By Type
9.2.2. By Psychotropic Agent
9.2.3. By Form
9.2.4. By Distribution Channel
9.2.5. By Application
9.2.6. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. China Psychobiotics
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Psychotropic Agent
9.3.1.2.3.
By Form
9.3.1.2.4.
By Distribution Channel
9.3.1.2.5.
By Application
9.3.2. India Psychobiotics
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Psychotropic Agent
9.3.2.2.3.
By Form
9.3.2.2.4.
By Distribution Channel
9.3.2.2.5.
By Application
9.3.3. South Korea
Psychobiotics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Psychotropic Agent
9.3.3.2.3.
By Form
9.3.3.2.4.
By Distribution Channel
9.3.3.2.5.
By Application
9.3.4. Japan Psychobiotics
Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Psychotropic Agent
9.3.4.2.3.
By Form
9.3.4.2.4.
By Distribution Channel
9.3.4.2.5.
By Application
9.3.5. Australia
Psychobiotics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Type
9.3.5.2.2.
By Psychotropic Agent
9.3.5.2.3.
By Form
9.3.5.2.4.
By Distribution Channel
9.3.5.2.5.
By Application
9.3.6. Taiwan Psychobiotics
Market Outlook
9.3.6.1.
Market Size & Forecast
9.3.6.1.1.
By Value
9.3.6.2.
Market Share & Forecast
9.3.6.2.1.
By Type
9.3.6.2.2.
By Psychotropic Agent
9.3.6.2.3.
By Form
9.3.6.2.4.
By Distribution Channel
9.3.6.2.5.
By Application
9.3.7. Malaysia
Psychobiotics Market Outlook
9.3.7.1.
Market Size & Forecast
9.3.7.1.1.
By Value
9.3.7.2.
Market Share & Forecast
9.3.7.2.1.
By Type
9.3.7.2.2.
By Psychotropic Agent
9.3.7.2.3.
By Form
9.3.7.2.4.
By Distribution Channel
9.3.7.2.5.
By Application
9.3.8. Singapore
Psychobiotics Market Outlook
9.3.8.1.
Market Size & Forecast
9.3.8.1.1.
By Value
9.3.8.2.
Market Share & Forecast
9.3.8.2.1.
By Type
9.3.8.2.2.
By Psychotropic Agent
9.3.8.2.3.
By Form
9.3.8.2.4.
By Distribution Channel
9.3.8.2.5.
By Application
10. South America
Psychobiotics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value &
Volume
10.2.
Market Share & Forecast
10.2.1. By Type
10.2.2. By Psychotropic Agent
10.2.3. By Form
10.2.4. By Distribution Channel
10.2.5. By Application
10.2.6. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Psychobiotics
Market Outlook
10.3.1.1.